Physician profile
Daniel T Le
NPI 1518295682
$26,609.22
in general payments reported to CMS, 2019-2025
9 companies · $15.42 in 2025
The $15.42 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,167 · 2020: $2,481 · 2021: $444 · 2022: $1,114 · 2023: $342 · 2024: $15K · 2025: $15.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,790 · Travel and Lodging: $6,744 · Food and Beverage: $869.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,790.49 |
| Travel and Lodging | $6,743.77 |
| Food and Beverage | $868.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Microport Orthopedics INC | $26,213.11 | 2019-2024 | Mpo Hip System, Mpo Medial Pivot Knee |
| Pacira Therapeutics, INC. | $214.06 | 2019-2021 | |
| Stryker Corporation | $34.24 | 2021-2022 | |
| Smith+Nephew, INC. | $34.09 | 2024 | Pico 14 |
| Abbott Laboratories | $29.46 | 2023-2025 | Proclaim |
| Sanofi-Aventis U.S. LLC | $27.90 | 2023 | |
| Heron Therapeutics, INC. | $26.13 | 2022 | |
| Ferring Pharmaceuticals INC. | $17.28 | 2019 | |
| Si-Bone, INC. | $12.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Le listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.